Peregrine Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Peregrine Capital Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-273,852	Closed	-$12.9M	–	335
2022 Q3	$12.9M	Sell	273,852 -14,946	-5%	-$965K	0.42%	60
2022 Q2	$20.7M	Sell	288,798 -224	-0.1%	-$16.4K	0.62%	29
2022 Q1	$23.4M	Sell	289,022 -21,219	-7%	-$1.79M	0.55%	34
2021 Q4	$31.9M	Sell	310,241 -24,571	-7%	-$2.36M	0.64%	31
2021 Q3	$29.3M	Sell	334,812 -65,047	-16%	-$5.89M	0.61%	32
2021 Q2	$35.8M	Sell	399,859 -20,574	-5%	-$1.74M	0.64%	34
2021 Q1	$31.9M	Sell	420,433 -58,238	-12%	-$4.39M	0.59%	35
2020 Q4	$32.6M	Sell	478,671 -43,571	-8%	-$2.72M	0.62%	38
2020 Q3	$27.8M	Buy	522,242 +3,161	+0.6%	+$188K	0.74%	30
2020 Q2	$30.2M	Sell	519,081 -17,330	-3%	-$931K	0.86%	24
2020 Q1	$21.1M	Sell	536,411 -121,075	-18%	-$7.08M	0.76%	33
2019 Q4	$39.1M	Sell	657,486 -7,604	-1%	-$409K	1%	10
2019 Q3	$35.4M	Buy	665,090 +21,925	+3%	+$1.13M	0.96%	10
2019 Q2	$32.9M	Sell	643,165 -1,497	-0.2%	-$69.7K	0.81%	16
2019 Q1	$33.4M	Sell	644,662 -13,380	-2%	-$649K	0.83%	13
2018 Q4	$25.9M	Sell	658,042 -3,959	-0.6%	-$184K	0.73%	30
2018 Q3	$34.1M	Buy	662,001 +17,510	+3%	+$857K	0.81%	17
2018 Q2	$30.2M	Buy	+644,491	New	+$26.7M	0.76%	29

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Peregrine Capital Management's SYNH Position: Q4 2022 in Review

Peregrine Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 273,852 shares — an estimated $12.9M sold.

Peregrine Capital Management first reported a position in SYNH in Q2 2018 and held it in 18 quarters. The position peaked at $39.1M in Q4 2019. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

Peregrine Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Peregrine Capital Management sold 273,852 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $12.9M.
Peregrine Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2018 and held it in 18 quarters.
Peregrine Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $39.1M in Q4 2019.
307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on Peregrine Capital Management's 13F filing for Q4 2022, filed 10 Jan 2023.